Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Tricida Inc (TCDA)

4.52   -0.2 (-4.24%) 03-05 09:13
Open: 4.6 Pre. Close: 4.72
High: 4.68 Low: 4.29
Volume: 1,174,817 Market Cap: 227M
Tricida, Inc., a pharmaceutical company, focuses on the development and commercialization of its drug candidate, TRC101, a non-absorbed, orally-administered polymer designed as a potential treatment for metabolic acidosis in patients with chronic kidney disease (CKD). The company has completed a Phase 3, double-blind, placebo-controlled trial of TRC101 in patients with CKD and metabolic acidosis. Tricida, Inc. was founded in 2013 and is headquartered in South San Francisco, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.689 - 4.716 4.716 - 4.745
Low: 4.22 - 4.248 4.248 - 4.278
Close: 4.465 - 4.516 4.516 - 4.57

Technical analysis

as of: 2021-03-05 8:52:51 AM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 7.80     One year: 9.53
Support: Support1: 4.29    Support2: 3.57
Resistance: Resistance1: 6.68    Resistance2: 8.16
Pivot: 6.28
Moving Average: MA(5): 4.83     MA(20): 6.52
MA(100): 7.24     MA(250): 15.33
MACD: MACD(12,26): -0.58     Signal(9): -0.31
Stochastic oscillator: %K(14,3): 4.39     %D(3): 4.04
RSI: RSI(14): 28.78
52-week: High: 32.99  Low: 3.74  Change(%): -86.2
Average Vol(K): 3-Month: 92273  10-Days: 160994

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
TCDA has closed above bottom band by 8.5%. Bollinger Bands are 134.7% wider than normal. The large width of the bands suggest high volatility as compared to TCDA's normal range. The bands have been in this wide range for 3 bars. This is a sign that the current trend might continue.

Headline News

Thu, 04 Mar 2021
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Tricida, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 8, 2021 - TCDA - Yahoo Finance

Thu, 04 Mar 2021
Should You Hold Tricida Inc (TCDA) in Drug Manufacturers - Specialty & Generic Industry? - InvestorsObserver

Wed, 03 Mar 2021
TCDA FINAL DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Tricida Inc. Investors to Secure Counsel Before Important Monday Deadline - TCDA - Yahoo Finance

Wed, 03 Mar 2021
Should Drug Manufacturers - Specialty & Generic Stock Tricida Inc (TCDA) Be in Your Portfolio Wednesday? - InvestorsObserver

Wed, 03 Mar 2021
Tricida Granted Additional U.S. Patent Covering Composition of Matter of Veverimer - GlobeNewswire

Tue, 02 Mar 2021
Tricida, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit - Yahoo Finance

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers General Specialty & Generic
Shares Out. (M) 50
Shares Float (M) 27
% Held by Insiders 2.74
% Held by Institutions 91.62
Shares Short (K) 4,620
Shares Short P. Month (K) 4,260

Stock Financials

EPS -5.370
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 3.200
Profit Margin
Operating Margin
Return on Assets (ttm) -41.8
Return on Equity (ttm) -113.5
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -5.172
Qtrly Earnings Growth
Operating Cash Flow (M) -219
Levered Free Cash Flow (M) -123

Stock Valuations

PE Ratio -0.84
PEG Ratio
Price to Book value 1.41
Price to Sales
Price to Cash Flow -1.04

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.